Join
Live feed
·
PRReleasevia Quantisnow
Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

ByQuantisnow·Wall Street's wire, on your screen.
TNXP· Tonix Pharmaceuticals Holding Corp.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNXP (Tonix Pharmaceuticals Holding Corp.) and more on Quantisnow.